🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesType 1.5 diabetes (LADA) and GLP-1 — what worked for you? Page 2

Type 1.5 diabetes (LADA) and GLP-1 — what worked for you?

pete_manc_UK Sun, Mar 16, 2025 at 5:43 AM 36 replies 2,172 viewsPage 2 of 8
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Mar 16, 2025 at 7:53 AM#6
TrialNerd_Beth said:
Fasting insulin is the lab my functional medicine doctor cares about most for glycaemic control: it's a much earlier marker of metabolic dysfunction…

Complete metabolic panel trending on glycaemic control — sharing because comprehensive data helps everyone:

TestBaselineMonth 3Month 6Month 12
Glucose (fasting)1191099587
Insulin (fasting)2517117
HOMA-IR5.53.02.31.3
Uric Acid7.76.96.25.0

The insulin resistance improvement (HOMA-IR) is what my endo focuses on most. Going from 5.5 to near 1.0 is a metabolic transformation.

16 11paul_denver, TinaHashiRN, robert_kc and 13 others
Reply Quote Save Share Report
DoseLogDan
Member
201
567
Feb 2025
Montana
Mar 16, 2025 at 8:43 AM#7
pete_manc_UK said:
Fasting glucose improved within weeks and my HbA1c barely moved for three months, which I now understand and did not at the time.

My labs after 9 months on glycaemic control: A1C 5.6%, fasting glucose 81 mg/dL, fasting insulin 4 uIU/mL. My endo says these are "textbook perfect."

For context, my baseline A1C was 7.7% and fasting glucose was 116 mg/dL. The improvement has been dramatic and consistent.

15 10Dr.AddMedPHL, newstart_MO, mia_MS2 and 12 others
Reply Quote Save Share Report
hyun_seoul
Member
345
1,456
Jul 2024
Seoul, KR
Mar 16, 2025 at 9:33 AM#8
PharmD_Rodriguez said:
Complete metabolic panel trending on glycaemic control — sharing because comprehensive data helps everyone: Test Baseline Month 3 Month 6 Month 12…

PCOS success story with glycaemic control: as someone with polycystic ovary syndrome, this medication has been transformative beyond weight loss.

After 10 months: periods became regular for the first time in years, testosterone levels normalized, acne cleared significantly, and — unexpectedly — I got pregnant naturally after 4 years of trying.

GLP-1 agonists address the insulin resistance at the root of PCOS. For PCOS patients, this isn't "just" a weight loss drug — it's treating our underlying metabolic dysfunction.

Last edited: Mar 16, 2025 at 1:33 PM
14 9MASHdoc_SA, GenomicsKate, Dr.ObesityMed and 11 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
fiona_glasgow
Member
312
1,345
Aug 2024
Glasgow, UK
Mar 16, 2025 at 10:23 AM#9

Following on from hank_denver — and this may be the naive question:

What would you measure differently if you were starting again?

13 8JessicaH_TX, KevinCompounds, TirzTom and 10 others
Reply Quote Save Share Report
pete_manc_UK
Senior Member
1,234
5,678
Mar 2024
Manchester, UK
Mar 16, 2025 at 2:23 PM#10
hyun_seoul said:
PCOS success story with glycaemic control: as someone with polycystic ovary syndrome, this medication has been transformative beyond weight loss.

Insulin sensitivity test (HOMA-IR) on glycaemic control — arguably the most important metabolic marker most people aren't tracking:

HOMA-IR = (fasting insulin × fasting glucose) ÷ 405

My numbers: Baseline HOMA-IR = 6.0 (insulin resistant) → Current = 1.4 (insulin sensitive)

Anything above 2.0 indicates insulin resistance. The goal is below 1.5. GLP-1 agonists address the root metabolic dysfunction, not just the symptoms. This is why they work so much better than calorie restriction alone.

21 19mike.trainer_LA, sarah_nash92, FitDadDave and 18 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register